Verification evidence is still being completed.
ICON Germany
Frankfurt, Germany
- Verified lead
- Barry Balfe
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Clinical Research Operations, Monitoring, and Trial Delivery Services
- Review cycle
- May 2026
- Full address
- Frankfurt, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ICON CEO transition release confirming Barry Balfe as CEO.
- Editorial note
- ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Clinical Research Operations, Monitoring, and Trial Delivery Services
GCP-aligned full-service CRO platform, Clinical and data-governance controls
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
- Lead
- Barry Balfe (verified ↗)
- Address
- Frankfurt, Germany (source ↗)
- Compliance
- GCP-aligned full-service CRO platform
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Global CRO network with Germany execution node
- Capabilities
- Clinical Monitoring · Trial Management · Clinical Data Delivery
- Founded
- 1990
- Headcount
- 10000+
- Company page (open ↗)
Barry Balfe
Chief Executive Officer
Official ICON Germany careers page listing Frankfurt as an active Germany location.
Open sourceGlobal CRO network with Germany execution node
Frankfurt, Germany. Clinical Research Operations, Monitoring, and Trial Delivery Services. Review completed on 14 Mar 2026.
German, EU, and global clinical-trial oversight
GCP-aligned full-service CRO platform, Clinical and data-governance controls
Clinical Research Operations, Monitoring, and Trial Delivery Services
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is ICON Germany located?
- ICON Germany operates from Frankfurt, Germany, Frankfurt, Germany.
- Who runs ICON Germany?
- ICON Germany is led by Barry Balfe, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does ICON Germany hold?
- ICON Germany is documented under GCP-aligned full-service CRO platform.
- What does ICON Germany do?
- ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node. Core capabilities: Clinical Monitoring, Trial Management, Clinical Data Delivery, Sponsor Support.
Related technical briefs
Briefs that name Frankfurt as a covered market or city.
